Projects per year
Search results
-
Active
A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 52-Week, Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Non-Cystic Fibrosis Bronchiectasis (MAHALE)
Stirling, R. (Primary Chief Investigator (PCI))
22/06/21 → 31/12/25
Project: Research
-
Establishing a Jeffrey Modell Center in Melbourne, Australia.
van Zelm, M. (Primary Chief Investigator (PCI)), Choo, S. (Chief Investigator (CI)), Bosco, J. J. (Chief Investigator (CI)), Slade, C. (Chief Investigator (CI)), Bryant, V. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Barnes, S. (Chief Investigator (CI)), Holdsworth, S. (Chief Investigator (CI)), Gowdie, P. (Chief Investigator (CI)), Douglass, J. A. (Chief Investigator (CI)), Unglik, G. (Chief Investigator (CI)), Richards, S. (Chief Investigator (CI)), Smart, J. M. (Chief Investigator (CI)), Mehr, S. (Chief Investigator (CI)), Akikusa, J. D. (Chief Investigator (CI)), Allen, R. (Chief Investigator (CI)), Cole, T. S. (Chief Investigator (CI)), Taranto, M. (Chief Investigator (CI)), Stirling, R. (Chief Investigator (CI)), Cameron, P. U. (Chief Investigator (CI)), O'Hehir, R. (Chief Investigator (CI)), Gugasyan, R. (Chief Investigator (CI)), Masters, S. L. (Chief Investigator (CI)) & Moghaddas, F. (Chief Investigator (CI))
19/10/17 → 30/06/26
Project: Research